https://www.bloomberg.com/authors/ASSYAz88eBc/johannes-kochhttps://www.bloomberg.com/feeds/static/images/bloomberg_logo_black.pnghttps://www.bloomberg.com/authors/ASSYAz88eBc/johannes-kochRSS for NodeTue, 21 Apr 2026 06:07:27 GMThttps://www.bloomberg.com/news/articles/2017-04-27/bayer-raises-profit-outlook-says-cfo-will-leave-next-yearhttps://www.bloomberg.com/news/articles/2017-04-27/bayer-raises-profit-outlook-says-cfo-will-leave-next-yearThu, 27 Apr 2017 05:52:45 GMThttps://www.bloomberg.com/news/articles/2017-04-24/becton-s-24-billion-bard-purchase-caps-string-of-acquisitionshttps://www.bloomberg.com/news/articles/2017-04-24/becton-s-24-billion-bard-purchase-caps-string-of-acquisitionsMon, 24 Apr 2017 10:49:42 GMThttps://www.bloomberg.com/news/articles/2017-04-11/german-police-say-one-injured-by-three-blasts-on-soccer-team-bushttps://www.bloomberg.com/news/articles/2017-04-11/german-police-say-one-injured-by-three-blasts-on-soccer-team-busTue, 11 Apr 2017 18:37:49 GMTA view of the stadium after the match was postponed amid an explosion near the bus of Borussia Dortmund some 10km away from the stadium prior to the UEFA Champions League 1st leg quarter-final football match BVB Borussia Dortmund v Monaco in Dortmund, western Germany on April 11, 2017. / AFP PHOTO / Odd ANDERSEN (Photo credit should read ODD ANDERSEN/AFP/Getty Images)https://www.bloomberg.com/news/articles/2017-04-10/all-nighter-in-stada-s-german-spa-town-ends-in-bain-cinven-winhttps://www.bloomberg.com/news/articles/2017-04-10/all-nighter-in-stada-s-german-spa-town-ends-in-bain-cinven-winMon, 10 Apr 2017 15:58:38 GMThttps://www.bloomberg.com/news/articles/2017-03-29/stada-struggles-for-consistency-in-key-markets-amid-deal-talkshttps://www.bloomberg.com/news/articles/2017-03-29/stada-struggles-for-consistency-in-key-markets-amid-deal-talksWed, 29 Mar 2017 05:48:13 GMThttps://www.bloomberg.com/news/articles/2017-02-22/bayer-fourth-quarter-profit-beats-estimates-helped-by-drugshttps://www.bloomberg.com/news/articles/2017-02-22/bayer-fourth-quarter-profit-beats-estimates-helped-by-drugsWed, 22 Feb 2017 06:40:57 GMThttps://www.bloomberg.com/news/articles/2017-02-16/bidding-war-for-stada-unlikely-to-lift-price-after-9-month-rallyhttps://www.bloomberg.com/news/articles/2017-02-16/bidding-war-for-stada-unlikely-to-lift-price-after-9-month-rallyThu, 16 Feb 2017 05:55:07 GMThttps://www.bloomberg.com/news/articles/2017-01-26/j-jto-buy-actelion-for-30-billion-spin-off-research-operationshttps://www.bloomberg.com/news/articles/2017-01-26/j-jto-buy-actelion-for-30-billion-spin-off-research-operationsThu, 26 Jan 2017 06:32:39 GMThttps://www.bloomberg.com/news/articles/2017-01-25/newron-in-talks-to-license-schizophrenia-drug-tipped-blockbusterhttps://www.bloomberg.com/news/articles/2017-01-25/newron-in-talks-to-license-schizophrenia-drug-tipped-blockbusterWed, 25 Jan 2017 07:01:57 GMThttps://www.bloomberg.com/news/articles/2017-01-10/valeant-to-sell-skincare-brands-to-l-oreal-for-1-3-billionhttps://www.bloomberg.com/news/articles/2017-01-10/valeant-to-sell-skincare-brands-to-l-oreal-for-1-3-billionTue, 10 Jan 2017 07:46:17 GMThttps://www.bloomberg.com/news/articles/2016-12-14/sanofi-actelion-under-pressure-for-deal-after-past-failureshttps://www.bloomberg.com/news/articles/2016-12-14/sanofi-actelion-under-pressure-for-deal-after-past-failuresWed, 14 Dec 2016 23:00:01 GMThttps://www.bloomberg.com/news/articles/2016-12-12/stada-s-independence-in-the-crosshairs-on-takeover-speculationhttps://www.bloomberg.com/news/articles/2016-12-12/stada-s-independence-in-the-crosshairs-on-takeover-speculationMon, 12 Dec 2016 07:01:35 GMThttps://www.bloomberg.com/news/articles/2016-12-06/j-j-woos-billionaire-doctors-who-don-t-need-cash-in-actelion-bidhttps://www.bloomberg.com/news/articles/2016-12-06/j-j-woos-billionaire-doctors-who-don-t-need-cash-in-actelion-bidTue, 06 Dec 2016 06:40:45 GMThttps://www.bloomberg.com/news/articles/2016-11-21/novartis-buys-blood-disorder-drug-owner-for-up-to-665-millionhttps://www.bloomberg.com/news/articles/2016-11-21/novartis-buys-blood-disorder-drug-owner-for-up-to-665-millionMon, 21 Nov 2016 08:14:25 GMThttps://www.bloomberg.com/news/articles/2016-11-15/merck-kgaa-s-third-quarter-profit-jumps-boosts-year-forecasthttps://www.bloomberg.com/news/articles/2016-11-15/merck-kgaa-s-third-quarter-profit-jumps-boosts-year-forecastTue, 15 Nov 2016 06:16:38 GMThttps://www.bloomberg.com/news/articles/2016-11-14/bayer-warns-planned-german-price-curbs-may-restrict-drug-accesshttps://www.bloomberg.com/news/articles/2016-11-14/bayer-warns-planned-german-price-curbs-may-restrict-drug-accessMon, 14 Nov 2016 05:30:00 GMThttps://www.bloomberg.com/news/articles/2016-11-03/novo-braces-for-new-threat-from-roche-for-blood-disorder-drugshttps://www.bloomberg.com/news/articles/2016-11-03/novo-braces-for-new-threat-from-roche-for-blood-disorder-drugsThu, 03 Nov 2016 05:00:00 GMThttps://www.bloomberg.com/news/articles/2016-10-28/novo-s-diabetes-pain-spares-sanofi-in-tale-of-two-strategieshttps://www.bloomberg.com/news/articles/2016-10-28/novo-s-diabetes-pain-spares-sanofi-in-tale-of-two-strategiesFri, 28 Oct 2016 10:03:33 GMThttps://www.bloomberg.com/news/articles/2016-10-28/novo-nordisk-pares-its-long-term-earnings-growth-target-to-5https://www.bloomberg.com/news/articles/2016-10-28/novo-nordisk-pares-its-long-term-earnings-growth-target-to-5Fri, 28 Oct 2016 05:39:53 GMThttps://www.bloomberg.com/news/articles/2016-10-26/bayer-profit-gains-as-drugs-eclipse-crops-before-monsanto-dealhttps://www.bloomberg.com/news/articles/2016-10-26/bayer-profit-gains-as-drugs-eclipse-crops-before-monsanto-dealWed, 26 Oct 2016 05:38:21 GMT